Lisinopril vs calcium channel blockers
Pro Research Analysisby 
Searched over 200M research papers
Blood Pressure Reduction: Lisinopril vs Calcium Channel Blockers
Calcium channel blockers (CCBs), especially amlodipine, generally provide greater blood pressure reduction and a higher rate of achieving target blood pressure compared to ACE inhibitors like lisinopril. Multiple studies have shown that CCBs are more effective in lowering blood pressure in adults with hypertension, although both drug classes are widely used and effective as monotherapy for mild to moderate hypertension 15.
Cardiovascular Outcomes and Major Events
Large clinical trials, such as the ALLHAT study, found that lisinopril (an ACE inhibitor) and amlodipine (a CCB) are equally effective in preventing major cardiovascular events like fatal coronary heart disease and nonfatal myocardial infarction. However, amlodipine and diuretics were more effective than lisinopril in preventing strokes, while lisinopril and diuretics were better at preventing heart failure 23. Overall, lowering blood pressure with either class reduces the risk and burden of cardiovascular disease .
Side Effects and Safety Profiles
ACE inhibitors like lisinopril are more likely to cause cough and renal issues, while CCBs, particularly amlodipine, are more often associated with peripheral edema (swelling, especially in the ankles) 14. The incidence of CCB-induced edema can be significant, affecting about 29% of patients in some studies. Adding lisinopril to CCB therapy can help reduce the severity and incidence of this edema, suggesting a role for ACE inhibitors in managing this side effect . Both drug classes are generally well tolerated, with most side effects considered mild, but individual distress from side effects can influence adherence to therapy .
Combination Therapy and Special Considerations
Combining lisinopril with a CCB like amlodipine can result in a greater reduction in blood pressure than either drug alone, and may be especially useful for patients who do not reach target blood pressure with monotherapy . In patients with left ventricular hypertrophy, the combination of an ACE inhibitor and a CCB is more effective at reducing heart muscle thickness than the combination of an ACE inhibitor and a diuretic .
Renal Protection and Proteinuria
Lisinopril has a unique benefit in reducing proteinuria (protein in the urine), which is important for patients with kidney disease. In studies of patients with nondiabetic renal failure, lisinopril reduced proteinuria, while amlodipine did not show this effect. However, lisinopril may also cause a small decrease in kidney filtration rate (GFR) .
Additional Effects
Both lisinopril and CCBs like nifedipine can reduce calcium uptake by platelets, which may help lower the risk of vascular complications in patients with diabetes and hypertension . In experimental models, lisinopril may improve heart contractility and heart rate during episodes of reduced blood flow to the heart, while CCBs like verapamil can help increase coronary blood flow .
Conclusion
Calcium channel blockers generally provide greater blood pressure reduction and are more effective at achieving target blood pressure than ACE inhibitors like lisinopril, but are more likely to cause peripheral edema. Lisinopril is preferred for patients with proteinuria or those at risk for heart failure, and can help manage CCB-induced edema. Both drug classes are effective for reducing cardiovascular risk, and combination therapy can offer additional benefits for certain patients. The choice between lisinopril and a calcium channel blocker should be individualized based on blood pressure goals, side effect profiles, and patient-specific factors 123457810.
Sources and full results
Most relevant research papers on this topic